DB17775ExperimentalProtein Based Therapies
Larcaviximab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Envelope glycoprotein
- Also known as
- Immunoglobulin g1, anti-(ebolavirus glycoprotein) (human-mus musculus monoclonal c4g7 heavy chain), disulfide with human-mus musculus monoclonal c4g7 .kappa.-chain, dimer · Zmap component c4g7 · Zmapp component c4g7
- Code names
- C4G7
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Larcaviximab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account